Premium
Cotinga Pharmaceuticals Inc (COT)
TSXV
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
TORONTO and BOSTON, July 18, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 04, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical company advancing a...
TORONTO and BOSTON, May 22, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical company advancing a pipeline...
LONDON, Ontario and BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
LONDON, Ontario and BOSTON, May 24, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX-V:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
LONDON and BOSTON, May 04, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing...
TORONTO and TAMPA, Fla., Nov. 30 /PRNewswire-FirstCall/ -- Cott Corporation (NYSE: COT; TSX: BCB) announced today the expiration of the previously announced cash tender offer and consent...
TORONTO and TAMPA, Fla., Oct. 29 /PRNewswire-FirstCall/ -- Cott Corporation (NYSE: COT; TSX: BCB) announced today the commencement of a cash tender offer by its wholly owned subsidiary, Cott...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 156 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
| 260 | -0.025 | -41.6666666667 | 0.06 | 0.08 | 0.02 | 1471 | 0.04569133 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
